7% Off
Pidonex400 mg
Beacon Pharmaceuticals PLC
৳465.00
Add to cart
Generic medicine
Pidotimod: Brands, Price & Uses in Bangladesh
Pidotimod is a synthetic immunostimulant (immunomodulator) used as follows: Established/guideline-supported use Adjunctive/prophylactic reduction of recurrent respiratory tract infections (RRTIs):…
About Pidotimod
Indications of Pidotimod
Pidotimod is a synthetic immunostimulant (immunomodulator) used as follows:
Established/guideline-supported use
- Adjunctive/prophylactic reduction of recurrent respiratory tract infections (RRTIs): Pidotimod is used to reduce the frequency, duration, and severity of recurrent upper and lower respiratory tract infections (e.g., recurrent colds, pharyngitis, tonsillitis, otitis media, bronchitis), particularly in children with a history of frequent infections. Several randomized trials and a multi-society pediatric consensus statement support its use as a preventive/adjunctive immunomodulatory strategy in this setting.
Adjunct use requiring combination therapy
- Pidotimod is sometimes used alongside standard antibiotic or symptomatic treatment during an acute respiratory infection, or as add-on therapy in patients also receiving other supportive care, with the aim of shortening illness duration and lowering relapse/recurrence rates — it is not a treatment for the acute infection itself.
Evidence caveat
Note: The evidence base for Pidotimod is stronger and use is more established in some countries (e.g., parts of Europe and Asia) than in others; Pidotimod is not approved by the US FDA and is not a substitute for vaccination, antibiotics when indicated, or other standard-of-care infection treatment/prevention measures.
Dosage & Administration of Pidotimod
Recurrent respiratory tract infection prophylaxis/adjunct therapy
| Population | Typical dose | Regimen |
|---|---|---|
| Children (approx. 3 years and older, per local labeling) | 400 mg once or twice daily (oral solution/sachet) | Commonly given as a cyclic course, e.g., daily for 15 days, repeated for 2–3 monthly cycles, or per physician's regimen |
| Adults and adolescents | 400–800 mg once or twice daily (sachet/tablet) | Cyclic or continuous courses as directed by the prescriber, often for several weeks |
Exact dose, formulation, and course length should follow the prescribing physician's instructions and the approved local product label, as regimens vary by country and product.
Pidotimod is intended as a preventive/adjunctive course and is not a substitute for treating an acute infection with appropriate standard therapy (e.g., antibiotics when bacterial infection is diagnosed).
Side Effects of Pidotimod
Pidotimod is generally well tolerated. Reported adverse effects include:
Common
- Gastrointestinal disturbances: nausea, vomiting, diarrhea, abdominal discomfort.
Uncommon/rare
- Skin reactions: rash, urticaria, itching.
- Hypersensitivity reactions, including rare reports of more severe allergic reactions.
- Headache or mild dizziness.
Patients should seek medical attention if signs of an allergic reaction (swelling, difficulty breathing, severe rash) occur.
Contraindications of Pidotimod
Pidotimod is contraindicated in:
- Patients with known hypersensitivity to Pidotimod or to any excipient in the specific formulation.
Frequently Asked Questions about Pidotimod
What is Pidotimod used for?
Pidotimod is a synthetic immunostimulant used mainly to reduce the frequency, duration, and severity of recurrent respiratory tract infections (such as frequent colds, tonsillitis, otitis media, or bronchitis), particularly in children. It is used as a preventive/adjunctive measure, not as a treatment for an active infection by itself.
Can Pidotimod replace antibiotics or vaccines?
No. Pidotimod is not an antibiotic and does not have direct antimicrobial activity, and it does not replace routine vaccination. It should be used alongside, not instead of, standard-of-care treatment (such as antibiotics when a bacterial infection is diagnosed) and recommended immunizations.
What is the usual dose of Pidotimod?
The usual dose of Pidotimod is 400 mg once or twice daily by mouth, often given in cyclic courses (for example, daily for about 15 days, repeated over 2–3 months). The exact dose, formulation, and duration should be determined by a physician based on age and clinical need.
Is Pidotimod safe during pregnancy or breastfeeding?
Data on Pidotimod use during pregnancy and breastfeeding are limited. It should be used in these situations only if a physician determines the potential benefit justifies the potential risk, and only under medical supervision — pregnant or breastfeeding individuals should consult their doctor before taking Pidotimod.
What are the common side effects of Pidotimod?
Pidotimod is generally well tolerated. The most common side effects are mild gastrointestinal symptoms such as nausea, vomiting, diarrhea, or abdominal discomfort. Less commonly, skin rash, itching, or hypersensitivity reactions can occur. Seek medical attention if signs of a serious allergic reaction develop.
Who should not take Pidotimod?
Pidotimod should not be used by anyone with a known hypersensitivity (allergy) to Pidotimod or to any ingredient in the specific product formulation. Patients with autoimmune conditions or those on immunosuppressive therapy should use Pidotimod only under medical supervision.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.